All In Biotech

Free tool

FAERS Monitor: Depakote

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019680 or its brand name (Depakote, Divalproex Sodium). Reports on generic versions are filed under their own applications.

Reports

42,540

Serious

29,035

68% of reports

Hospitalization

14,288

Death reported

2,388

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective2,910
  • seizure2,465
  • weight increased1,996
  • off label use1,989
  • nausea1,960
  • fatigue1,819
  • pain1,809
  • somnolence1,753
  • tremor1,643
  • fall1,640
  • anxiety1,604
  • vomiting1,537
  • headache1,474
  • insomnia1,435
  • depression1,433

Reports by year received

View as table
YearReports
20041,146
20051,255
20061,190
20071,179
20081,195
20092,479
20102,155
20112,052
20122,043
20131,760
20141,854
20152,475
20162,644
20172,205
20182,092
20192,129
20201,907
20211,991
20222,047
20231,770
20241,783
20251,875
20261,309

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,011,619 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
seizureSignal2,46510.810.421,464
tremorSignal1,6434.94.75,138
weight increasedSignal1,9964.44.35,321
somnolenceSignal1,7534.34.14,496
depressionSignal1,4333.13.02,081
anxietySignal1,6042.82.71,865
insomniaSignal1,4352.72.51,512
fallSignal1,6402.42.31,412
vomiting1,5371.61.5370
pain1,8091.51.4266
nausea1,9601.21.284
headache1,4741.21.134
fatigue1,8191.21.139
off label use1,9891.11.128
drug ineffective2,9101.11.124

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.